Wedge Capital Management L L P NC lessened its stake in HCA Healthcare Inc (NYSE:HCA) by 29.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 102,613 shares of the company’s stock after selling 43,630 shares during the period. Wedge Capital Management L L P NC’s holdings in HCA Healthcare were worth $14,276,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. Smithfield Trust Co. boosted its position in HCA Healthcare by 541.9% in the 2nd quarter. Smithfield Trust Co. now owns 995 shares of the company’s stock worth $102,000 after purchasing an additional 840 shares in the last quarter. Signet Financial Management LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $137,000. Adviser Investments LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $159,000. Ballentine Partners LLC purchased a new stake in HCA Healthcare in the 3rd quarter worth approximately $222,000. Finally, Harvest Fund Management Co. Ltd purchased a new stake in HCA Healthcare in the 3rd quarter worth approximately $234,000. Institutional investors and hedge funds own 70.84% of the company’s stock.
In related news, SVP Deborah M. Reiner sold 723 shares of the stock in a transaction on Monday, November 5th. The stock was sold at an average price of $135.06, for a total value of $97,648.38. Following the completion of the transaction, the senior vice president now directly owns 6,184 shares of the company’s stock, valued at approximately $835,211.04. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Jane D. Englebright sold 6,543 shares of the stock in a transaction on Wednesday, August 15th. The shares were sold at an average price of $129.86, for a total value of $849,673.98. Following the completion of the transaction, the senior vice president now directly owns 7,443 shares of the company’s stock, valued at $966,547.98. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,462 shares of company stock valued at $1,656,680. 2.80% of the stock is owned by corporate insiders.
Shares of HCA stock opened at $135.36 on Tuesday. The company has a market cap of $46.52 billion, a PE ratio of 20.54, a price-to-earnings-growth ratio of 1.18 and a beta of 0.48. HCA Healthcare Inc has a 1-year low of $74.26 and a 1-year high of $141.11.
HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The firm had revenue of $11.45 billion during the quarter, compared to the consensus estimate of $11.29 billion. During the same period in the prior year, the company earned $1.13 EPS. The firm’s revenue was up 7.1% compared to the same quarter last year. Research analysts anticipate that HCA Healthcare Inc will post 9.33 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be paid a $0.35 dividend. This represents a $1.40 annualized dividend and a yield of 1.03%. The ex-dividend date of this dividend is Friday, November 30th. HCA Healthcare’s dividend payout ratio is currently 21.24%.
HCA has been the topic of several recent research reports. Jefferies Financial Group upped their price objective on HCA Healthcare to $155.00 and gave the stock a “buy” rating in a research report on Friday, September 21st. Leerink Swann upped their price objective on HCA Healthcare from $140.00 to $150.00 and gave the stock an “outperform” rating in a research report on Tuesday, September 4th. Mizuho set a $150.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research note on Tuesday, September 4th. Argus upped their target price on HCA Healthcare to $150.00 and gave the stock a “buy” rating in a research note on Friday, September 7th. Finally, Royal Bank of Canada upped their target price on HCA Healthcare to $150.00 and gave the stock an “outperform” rating in a research note on Monday, September 10th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $141.26.
COPYRIGHT VIOLATION WARNING: “Wedge Capital Management L L P NC Sells 43,630 Shares of HCA Healthcare Inc (HCA)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/11/06/wedge-capital-management-l-l-p-nc-sells-43630-shares-of-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
See Also: Fundamental Analysis
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.